Soprano@Soprano

3Settimana

Have you read up on who the stuff is actually intended for and who the most important target groups of "prep" are?

Mostra originale (Tedesco)

Mi piace••Risposta

Tenbagger2024@Tenbagger2024

3Settimana

@Soprano
The company has a large pipeline, so not just the one drug.
I took a look at the estimates.
Earnings per share go up from 4.39 to 7.48.
Free cash flow from 9397.86 to 10433.23
EbiT margin from 29 to 43
Turnover continues to rise.
The P/E ratio falls to 13

Mostra originale (Tedesco)

Mi piace•

👍

11

•Risposta

DerJude@DerJude

2Settimana

@Tenbagger2024 I've been in it myself since €59.26 😊

Mostra originale (Tedesco)

Mi piace••Risposta

Tenbagger2024@Tenbagger2024

2Settimana

@Ni485
Cool my dear,
Fundamentally, it doesn't look too bad.

Mostra originale (Tedesco)

Mi piace••Risposta